Is a complete BSEM research report available?

No complete published report is available for BioStem Technologies, Inc. (BSEM) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

BioStem Technologies, Inc. (BSEM)

NASDAQ: BSEM · USD

$3.61

-0.17 (-4.5%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-08-12 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first BSEM analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	64M
Revenue (ttm)	37.7M
Net income (ttm)	-19.3M
EPS (ttm)	-$1.15
Shares out	17.7M
Volume	41,420
Beta	0.26

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 37.7M
Net income (ttm): -19.3M
EPS (ttm): -$1.15
Market cap: 64M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	29.6B	39.4x	6.2x	96.6%	+47.5%	-49.6%	Strong Buy
ARGX	argenx SE	54.1B	31.5x	10.2x	50.6%	+58.8%	+30.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All BSEM indicators

Market & fundamental data

Available fields

205

Groups with data

Currency

USD

Showing 205 of 205 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001658678
Company name	BioStem Technologies, Inc.
Country	United States
Country code	US
Cusip	090684200
Employees	73
Enterprise value	$53.6M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-08-11
Industry	Biotechnology
Isin	US0906842002
Last refreshed	2026-08-12
Market cap	$64M
Market cap category	Micro-Cap
Price	$3.61
Price currency	USD
Rev Per Employee	515,760.6x
Sector	Healthcare
Sector PE	50.11
Sector PE Fwd	22.7
Symbol	BSEM
Website	https://biostemtechnologies.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-29.36%
EV Sales Forward	1.59x
EV/FCF	29.87x
EV/Sales	1.47x
FCF yield	2.82%
P/B ratio	2.01x
P/S ratio	1.75x
PS Forward	1.89x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-39.37%
EBITDA Margin	-37.5%
FCF margin	4.92%
Gross margin	87.87%
Gross Profit	$33.1M
Gross Profit Growth	5.54%
Gross Profit Growth Q	-75.13%
Gross Profit Growth3 Y	102.81%
Gross Profit Growth5 Y	189.12%
Net Income	$-19.3M
Net Income Growth Years	0%
Pretax Margin	-38.49%
Profit Margin	-51.28%
Profit Per Employee	$-264,503
ROA	-9.07
ROCE	-46.45
ROE	-48.64
ROIC	-86.27

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-12.68%
Cagr15y	-22.59%
Cagr1y	-65.15%
Cagr20y	-24.02%
Cagr3y	27.29%
Cagr5y	27.54%
EPS Growth Years	0
FCF Growth	-93.24%
OCF Growth	-81.99%
Revenue Growth	-13.89x
Revenue Growth Q	-61.57x
Revenue Growth Years	0x
Revenue Growth3 Y	100.48x
Revenue Growth5 Y	160.57x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.37
Assets	$55.1M
Cash	$13.7M
Current Assets	$26.5M
Current Liabilities	$23.2M
Debt	$3.3M
Debt Equity	$0.1
Debt FCF	$1.77
Equity	$31.9M
Liabilities	$23.2M
Long Term Assets	$28.6M
Long Term Liabilities	$44,638
Net Cash	$10.4M
Net Cash By Market Cap	$15.85
Net Cash Growth	-53.4%
Net Debt Equity	$-0.33
Net Debt FCF	$-5.63
Tangible Book Value	$8.5M
Tangible Book Value Per Share	$0.5
WACC	5.4

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.14
Inventory Turnover	1.41
Net Working Capital	$-7.2M
Quick ratio	0.86
Working Capital	$3.3M
Working Capital Turnover	$1.72

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	28.42%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-74.21%
1Y total return	-65.12%
200-day SMA	4.52
3Y total return	106.29%
50-day SMA	3.69
50-day SMA vs 200-day SMA	50under200
5Y total return	237.35%
All Time High	1,500,000,000
All Time High Change	-100%
All Time High Date	2007-01-19
All Time Low	0.01
All Time Low Change	36,000%
All Time Low Date	2020-12-03
ATR	0.44
Beta	0.26
Beta1y	2.12
Beta2y	1.88
Ch YTD	-5.25
High	3.72
High52	10.71
High52 Date	2025-08-13
High52ch	-66.29%
Low	3.54
Low52	3.01
Low52 Date	2026-08-03
Low52ch	19.93%
Ma50ch	-2.06%
Price vs 200-day SMA	-20.2%
RSI	49.22
RSI Monthly	43.81
RSI Weekly	41.7
Sharpe ratio	-0.36x
Sortino ratio	-0.52
Total Return	28.42%
Tr YTD	-5.25
Tr15y	-97.85%
Tr1m	-2.17%
Tr1w	10.8%
Tr3m	-19.78%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	$-14.8M
Operating margin	-39.37

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	13,998,733%
Float Percent	78.97%
Net Borrowing	-1,069,565
Shares Insiders	21.03%
Shares Institutions	0%
Shares Out	17,726,521
Shares Qo Q	1.52%
Shares Yo Y	-28.42%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-3.2M
Adjusted OCF	-29,599
Average Volume	63,711.2x
Bv Per Share	1.88
CAPEX	$-3.2M
Ch10y	-74.21
Ch15y	-97.85
Ch1m	-2.17
Ch1w	10.8
Ch1y	-65.12
Ch20y	-99.59
Ch3m	-19.78
Ch3y	106.3
Ch5y	237.4
Ch6m	-42.52
Change	-4.5%
Change From Open	-1.1
Close	3.78
Days Gap	-3.44
Depreciation Amortization	705,893
Dollar Volume	149,526.2
Earnings Date	2026-08-12
EBIT	$-14.8M
EBITDA	$-14.1M
EPS	$-1.15
F Score	3
FCF	$1.9M
FCF EV Yield	3.35x
FCF Per Share	$0.1
Financing CF	-1,054,565
Fiscal Year End	December
Founded	2,006
Goodwill	1,532,635
Income Tax	$4.8M
Investing CF	-16,957,031
Is Primary Listing	1
Is Spac	No
Last Report Date	2026-03-31
Last Split Date	2015-01-27
Last Split Type	Reverse
Ma150	4.64
Ma150ch	-22.13%
Ma20	3.66
Ma20ch	-1.34%
Net CF	-12,970,104
Open	3.65
P FCF Ratio	35.49
P OCF Ratio	13.04
Position In Range	38.89
Post Close	3.61
Postmarket Change Percent	1
Postmarket Price	$3.65
Ppne	5,180,124
Price Date	2026-08-11
Ptbv Ratio	7.75
Relative Volume	0.65x
Revenue	37,650,524x
SBC By Revenue	13.47x
Share Based Comp	5,071,090
Tax By Revenue	12.8x
Tr20y	-99.59%
Tr6m	-42.52%
Us State	Florida
Volume	41,420
Z Score	2.49

BioStem Technologies, Inc. (BSEM)

Coverage state: Market snapshot only — no published research

Generate the first BSEM analysis

Price

Financial snapshot

Fair-value bridge

Latest news · BSEM

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BSEM indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on BSEM

Frequently asked questions